Topical Treatment for EB Recommended for Approval in the EU Topical Treatment for EB Recommended for Approval in the EU

In February, the FDA declined to approve the company ' s new drug application as it was presented and asked the company to submit additional evidence of effectiveness for epidermolysis bullosa (EB).International Approvals
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Dermatology News Alert Source Type: news